Market Cap (In USD)
107.54 Million
Revenue (In USD)
-
Net Income (In USD)
-52.37 Million
Avg. Volume
366.56 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.76-5.09
- PE
- -
- EPS
- -
- Beta Value
- 0.039
- ISIN
- US00509G2093
- CUSIP
- 00509G209
- CIK
- 1576885
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Daniel J. O'Connell M.B.A.
- Employee Count
- -
- Website
- https://acumenpharm.com
- Ipo Date
- 2021-07-01
- Details
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
More Stocks
-
SKS
-
CWY
-
BYD
-
NOA
-
IVZ
-
CCZ
-
WEGYF
-
EGDD